Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD.
Alveolar macrophages (AM) participate actively in the inflammatory response that characterises chronic obstructive pulmonary disease (COPD). The present study investigated potential changes in AM phenotypes in patients with COPD. Using flow cytometry, the surface expression of receptors implicated in phagocytosis (CD44, CD36, CD51, CD61, CD14), antigen-presenting capacity (human leukocyte antigen (HLA)-DR), costimulatory molecules (CD80, CD86, CD40) and complement receptor type 3 were assessed in AM from 18 patients with COPD, 14 smokers with normal lung function and nine nonsmokers. When compared to smokers with normal lung function and nonsmokers, the surface expression of HLA-DR and CD80 was lower in AM of patients with COPD. In addition, these patients had a higher percentage of AM with a low level surface expression of CD44. There did not appear to be any difference in the other receptors studied in AM between the three groups. The expression of all these receptors in peripheral blood monocytes also did not differ between groups. In conclusion, these observations suggest that the cell-mediated immune function of alveolar macrophages can be reduced in chronic obstructive pulmonary disease, and that this is a local rather than a systemic event.
Pons
A R
AR
Serveis de Analisis Clinics, Pneumologia, Hospital Universitari Son Dureta, Institut Universitari de Investigacións en Ciències de la Salut (IUNICS), Palma de Mallorca, Spain.
Noguera
A
A
Blanquer
D
D
Sauleda
J
J
Pons
J
J
Agustí
A G N
AG
D006801:Humans; D008264:Macrophages / Q000276:immunology*; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D010641:Phenotype; D011650:Pulmonary Alveoli; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood*; D011956:Receptors, Cell Surface / Q000235:genetics / Q000276:immunology
D011956:Receptors, Cell Surface